Company / Working Capital
Cocrystal Pharma, Inc. Working Capital History
FY2012-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$57.8M
FY2021
5-year range
-$4.1M / $57.8M
FY2017-FY2021
Trend
+76.9%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has increased for 3 consecutive years, from -$4M in FY2012 to $58M in FY2021.
Based on SEC 10-K filings.
$58M in FY2021.
Improved from $6M to $58M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Cocrystal Pharma, Inc.'s working capital has grown for 3 consecutive years.
- In FY2021, working capital increased 76.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score 14.87 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $57.8M | +76.9% |
| FY2020 | $32.7M | +444.7% |
| FY2019 | $6.0M | +245.1% |
| FY2012 | -$4.1M | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026